![]() |
市場調査レポート
商品コード
1021768
CRO(医薬品開発業務受託機関)サービスの世界市場:市場規模、シェア、動向分析(2019年~2020年)と予測(2027年まで)Global Contract Research Organization (CRO) Services Market - Analysis of Market Size, Share & Trends for 2019 - 2020 and Forecast to 2027 |
CRO(医薬品開発業務受託機関)サービスの世界市場:市場規模、シェア、動向分析(2019年~2020年)と予測(2027年まで) |
出版日: 2021年08月06日
発行: SPER Market Research Pvt. Ltd.
ページ情報: 英文 215 Pages
納期: 即日から翌営業日
|
世界のCRO(医薬品開発業務受託機関)サービスの市場規模は、2020年から11.4%のCAGRで成長し、2027年には885億米ドルに達すると予測されています。同市場の主な成長要因には、医薬品の研究開発への投資の増加、臨床試験件数の増加、希少疾患の発生率の上昇などが挙げられます。ただし、高いスキルを持った専門家を確保することが大きな課題となっています。
当レポートは、世界のCRO(医薬品開発業務受託機関)サービス市場について調査しており、市場の成長および抑制要因、機会や課題、COVID-19パンデミックの影響、タイプ・治療分野・分子タイプ・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。
The global contract research organization (CRO) services market is expected to grow at a CAGR of 11.4% from 2020 to reach USD 88.5 billion by 2027. The growth is primarily attributed to increasing investment in pharmaceutical R&D, increasing number of clinical trials and rising incidence of orphan and rare diseases. However, retaining highly skilled professionals pose a significant challenge.
Clinical research services segment accounted for the largest share of CRO services market. The largest share of this segment is mainly due to rapidly increasing geriatric population, prevalence of chronic diseases and growing demand for newer drugs.
On the basis of therapeutic area, CRO services market is segmented into oncology, infectious diseases, neurology, cardiovascular system (CVS) disorders, metabolic disorders/endocrinology, immunological disorders, respiratory disorders, psychiatry, dermatology, haematology, ophthalmology, gastrointestinal diseases, genitourinary & women's health and other therapeutic areas. Oncology segment held largest share in the forecast period. The largest share of this segment is mainly attributed to high incidence of cancer and pipeline of drugs in late-stage development.
CRO services market is segmented into vaccines, cell & gene therapy and other molecules on the basis of molecule type. Cell & gene therapy is projected to reflect fastest growth during the forecast period mainly due to rising R&D expenditure in regenerative medicine and promising therapies in pipeline.
Based on the end user segregation, pharmaceutical & biopharmaceutical companies accounted for largest market share in 2020. The growth of this market can be mainly attributed to increasing outsourcing of early-phase development services and clinical & laboratory testing services by pharmaceutical companies.
In 2020, North America accounted for the largest share of CRO services market and is expected to follow the same trend in the forecast period. The largest share of this regional segment is mainly due to presence of leading pharmaceutical & biopharmaceutical companies and high investments in the biologics segment. The second dominant regional market for CRO services is expected to be Europe.